Colonics
About Me
Recent Posts
- Improving Health Care Access In Developing Countries, Remote Regions, Using Mobile Health Devices
- Protein Protects Against Breast Cancer Recurrence In Animal Model
- Light-Carved 'Nano-Volcanoes' Hold Promise For Drug Delivery
- Older People May Be Protected From Influenza By Their Saliva
- New Array Measures Vibrations Across The Skin, May Help Engineers Design Optimal, Wearable Tactile Displays
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
Friends
Links
Entry 1 of 2710
Last Page | Next Page
10/25/2010
-
Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint
|
Intercell AG today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine petitioner (IC43) against infections with the bacillus Pseudomonas aeruginosa, a leading cause of hospital-acquired infections with increasing antibiotic oppugnation and hence a very high unmet medical need. More: - The rest... |
:: Send to a Friend! |
Share and enjoy
Report this!